SEC Form 4 · accession 0001437749-18-005915

BIOLARGO, INC. · BLGO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Jack B. Strommen

Director

Period of report

Mar 28, 2018

Accepted (ET)

Mar 30, 2018 · 2:48 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000880242

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Convertible Promissory Note^F2,F1	$0.30	Mar 28, 2018	P	—	A	Mar 28, 2018	Apr 20, 2021	Common stock	333,333	—	I
Warrant to Purchase Common Stock^F3,F4	$0.48	Mar 28, 2018	P	333,333	A	Mar 28, 2018	Apr 20, 2023	Common stock	333,333	3,590,476	I

Explanation of responses

F1The maturity date of the Convertible Promissory Note is April 20, 2021.
F2Represents the amount of cash investment and the principal amount due on the Convertible Promissory Note reported herein.
F3The reported Warrant to Purchase Common Stock was received as part of a unit associated with a $100,000 investment by Reporting Person into Issuer's private securities offering, along with the Convertible Promissory Note reported herein. No separate consideration was given for the warrant.
F4Includes warrants to purchase 3,257,143 common stock held by Reporting Person directly. Does not include 82,138 shares of Issuer's common stock purchasable by Reporting Person pursuant to Options.

Remarks

The Convertible Promissory Note and Warrant reported in Table II were purchased as part of a unit in the issuer's private securities offering titled Spring 2018 Offering.